| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $1.04 (Beat by $0.072) |
| EPS GAAP Actual | $1.04 (Beat by $0.072) |
| Revenue Actual | $3.4521B |
| Revenue Surprise | Beat by $3452.1M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.83824 |
| EPS GAAP Estimate | $0.83824 |
| Revenue Estimate | $2.993001505B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.32 | 12.33 | 2.05974 | 2.57466 | 4 |
| Dec 2028 | 3.7 | 7.73 | 3.11908 | 4.41593 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.3 | 0.5781 | 3.4521B | 18.57% | 788.84M |
| FQ2 2025 (Jun 2025) | 1.29 | 0.56971 | 3.0057B | 6.29% | 348.02M |
| FQ1 2025 (Mar 2025) | 0.75 | 0.75 | 2.6209B | -2.23% | 2620.9M |
| FQ4 2024 (Dec 2024) | 0.53 | 0.53 | 2.8159B | -11.85% | 2815.9M |
| FQ3 2024 (Sep 2024) | 0.38 | 0.38 | 2.8109B | -26.23% | 2810.9M |
| FQ2 2024 (Jun 2024) | -0.5 | -0.5 | 2.8166B | -20.5% | 2816.6M |
| FQ1 2024 (Mar 2024) | 0.14 | 0.14 | 2.6794B | -34.52% | 2679.4M |
| FQ4 2023 (Dec 2023) | 1.12 | 1.12 | 3.1495B | 100% | 3149.5M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.83824
Consensus Revenue Estimates
2.993001505B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.90029 | -- | 0.87235 | 0.95014 | 1 |
| FQ3 2027 (Sep 2027) | -0.017842 | -- | -0.01910016 | -0.01572648 | 4 |
| FQ2 2027 (Jun 2027) | 0.3122 | -- | 0.27518 | 0.33422 | 3 |
| FQ1 2027 (Mar 2027) | 0.63525 | -- | 0.55993 | 0.68005 | 7 |
| FQ4 2026 (Oct 2026) | 0.024991 | -- | 0.02208929 | 0.02801779 | 3 |
| FQ3 2026 (Jul 2026) | 0.44963 | -189.13 | 0.39742 | 0.50409 | 5 |
| FQ2 2026 (Jun 2026) | 0.46855 | -175.32 | 0.42024 | 0.51158 | 5 |
| FQ1 2026 (Mar 2026) | 0.83824 | 10.53 | 0.75181 | 0.91521 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.07B | -- | 2.99B | 3.2B | 2 |
| FQ3 2027 (Sep 2027) | 2.89B | -- | 2.62B | 3.04B | 3 |
| FQ2 2027 (Jun 2027) | 2.78B | -- | 2.53B | 2.93B | 3 |
| FQ1 2027 (Mar 2027) | 2.86B | -- | 2.6B | 3.01B | 3 |
| FQ4 2026 (Oct 2026) | 2.79B | -- | 2.54B | 3.05B | 4 |
| FQ3 2026 (Jul 2026) | 2.76B | -25.05 | 2.51B | 3.02B | 5 |
| FQ2 2026 (Jun 2026) | 2.78B | -8.13 | 2.56B | 2.98B | 5 |
| FQ1 2026 (Mar 2026) | 2.99B | 12.43 | 2.76B | 3.2B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.7219 | 1.3 | 0.5781 | 44.47% |
| FQ2 2025 (Jun 2025) | 0.72029 | 1.29 | 0.56971 | 44.16% |
| FQ1 2025 (Mar 2025) | 0.75 | 0.75 | 100% | |
| FQ4 2024 (Dec 2024) | 0.53 | 0.53 | 100% | |
| FQ3 2024 (Sep 2024) | 0.38 | 0.38 | 100% | |
| FQ2 2024 (Jun 2024) | -0.5 | -0.5 | 100% | |
| FQ1 2024 (Mar 2024) | 0.14 | 0.14 | 100% | |
| FQ4 2023 (Dec 2023) | 1.12 | 1.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.66B | $3.45B | $788.84M | 22.85% |
| FQ2 2025 (Jun 2025) | $2.66B | $3.01B | $348.02M | 11.58% |
| FQ1 2025 (Mar 2025) | $0B | $2.62B | $2620.9M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.82B | $2815.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.81B | $2810.9M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.82B | $2816.6M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.68B | $2679.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.15B | $3149.5M | 100% |